The report, which synthesizes data from the OECD’s Health at a Glance 2025 and the U.S. Bureau of Labor Statistics, highlights how national healthcare economics drive the cost of residential care. Because inpatient rehabilitation is labor-intensive, the U.S. market must account for significantly higher clinical wages, property taxes, and administrative overhead. In contrast, Mexican facilities benefit from lower prevailing wages and operational expenses, allowing them to offer premium services at a fraction of the cost found north of the border.
While this macroeconomic environment explains the price difference, the analysis notes that lower costs do not inherently guarantee clinical equivalence. The report urges prospective patients to look beyond the price tag by verifying facility licensure through COFEPRIS, checking staff-to-guest ratios, and confirming professional credentials. As medical tourism continues to grow—with millions of Americans already traveling to Mexico for care—the findings suggest that the affordability of treatment in cities like Merida allows many families to extend their recovery duration, potentially improving long-term outcomes for the same budget required for a short-term stay in the United States.

Comments (0)
No comments yet. Be the first!